For the Three Months
Ended June 30, |
For the Six Months
Ended June 30, | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Non-GAAP Net Loss: | ||||||||||||||||
Net loss | $ | (26,559 | ) | $ | (16,549 | ) | $ | (44,902 | ) | $ | (36,544 | ) | ||||
Add (deduct): | ||||||||||||||||
Depreciation and amortization(1) | 2,895 | 2,008 | 5,461 | 3,807 | ||||||||||||
Stock-based compensation(2) | 5,798 | 5,479 | 10,492 | 8,935 | ||||||||||||
Amortization of lease intangible | 257 | 333 | 590 | 666 | ||||||||||||
Amortization of deferred costs on convertible notes | 464 | 469 | 930 | 781 | ||||||||||||
Loss on marketable securities | — | 332 | — | 1,190 | ||||||||||||
Acquisition and other (4) | 196 | (1,923 | ) | 226 | (1,284 | ) | ||||||||||
Loss on sale of property and equipment | 1 | — | 92 | 71 | ||||||||||||
Charitable contribution of common stock | — | 1,285 | 370 | 1,285 | ||||||||||||
Lease abandonment and termination (3) | 8,778 | — | 8,778 | — | ||||||||||||
Impairment of assets | 219 | 119 | 246 | 119 | ||||||||||||
Restructuring charge (5) | 738 | — | 738 | — | ||||||||||||
Costs to exit the supplies business | 586 | — | 586 | — | ||||||||||||
Non-GAAP Net Loss | $ | (6,627 | ) | $ | (8,447 | ) | $ | (16,393 | ) | $ | (20,974 | ) | ||||
Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted, of Class A and Class B common stock | 47,865,990 | 47,074,246 | 47,783,235 | 46,932,702 | ||||||||||||
EPS, basic and diluted, of Class A and Class B common stock | $ | (0.55 | ) | $ | (0.35 | ) | $ | (0.94 | ) | $ | (0.78 | ) | ||||
Non-GAAP EPS, basic and diluted, of Class A and Class B common stock | $ | (0.14 | ) | $ | (0.18 | ) | $ | (0.34 | ) | $ | (0.45 | ) |
Xometry Reports Second Quarter 2023 Results
| | More MCAD News |
|
RELATED NEWS